Pri­vate in­vest­ment firm snaps up Pfiz­er fa­cil­i­ty in West­ern Aus­tralia

Bridgewest Group, a pri­vate in­vest­ment firm, has signed a de­fin­i­tive agree­ment to pur­chase Pfiz­er’s ster­ile in­jectable fa­cil­i­ty in the town of Bent­ley, Aus­tralia, a sub­urb of Perth.

Ac­cord­ing to the group, the fa­cil­i­ty is ap­proved to sup­ply around 90 coun­tries with drug prod­ucts and has the OK from sev­er­al reg­u­la­tors in­clud­ing the FDA. The fa­cil­i­ty al­so has “ex­ten­sive” blow fill seal ca­pa­bil­i­ties for man­u­fac­tur­ing in­jecta­bles and op­er­a­tions to make on­col­o­gy drugs as well. Bridgewest will be ac­quir­ing sev­er­al drug prod­ucts from Pfiz­er to make and sell glob­al­ly, al­though the spe­cif­ic prod­ucts were not dis­closed.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.